Filing Details

Accession Number:
0001209191-10-002754
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2010-01-11 12:00:00
Reporting Period:
2010-01-04
Filing Date:
2010-01-11
Accepted Time:
2010-01-11 20:37:27
Original Submission Date:
2010-01-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
858803 Avanir Pharmaceuticals Inc. AVNR Pharmaceutical Preparations (2834) 330314804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314596 Keith Katkin 101 Enterprise, Suite 300
Aliso Viejo CA 92656
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-04 46,685 $1.97 458,487 No 4 F Direct
Common Stock Disposition 2010-01-04 4,872 $1.97 453,615 No 4 F Direct
Common Stock Disposition 2010-01-04 900 $1.88 452,715 No 4 S Direct
Common Stock Disposition 2010-01-04 2,600 $1.90 450,115 No 4 S Direct
Common Stock Disposition 2010-01-04 15,000 $1.90 435,115 No 4 S Direct
Common Stock Disposition 2010-01-04 1,500 $1.91 433,615 No 4 S Direct
Common Stock Disposition 2010-01-05 925 $1.93 432,690 No 4 S Direct
Common Stock Disposition 2010-01-05 3,100 $1.93 429,590 No 4 S Direct
Common Stock Disposition 2010-01-05 100 $1.93 429,490 No 4 S Direct
Common Stock Disposition 2010-01-05 900 $1.94 428,590 No 4 S Direct
Common Stock Disposition 2010-01-05 2,000 $1.94 426,590 No 4 S Direct
Common Stock Disposition 2010-01-05 2,000 $1.96 424,590 No 4 S Direct
Common Stock Disposition 2010-01-05 6,000 $1.96 418,590 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due upon the vesting of Restricted Stock Units granted to the Reporting Person under the Issuer's 2003 Equity Incentive Plan. The shares surrendered were valued based on the closing price of the Issuer's common stock on the vesting date.
  2. The number of shares surrendered to the Issuer by the Reporting Person was reported incorrectly on the Reporting Person's original Form 4. The Reporting Person had to surrender fewer shares than originally anticipated to cover the necessary withholding taxes.
  3. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
  4. The total amount of securities beneficially owned by the Reporting Person is corrected in connection with the amendment shown on the first line of this Form 4.
  5. Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due upon the vesting of Restricted Stock Units granted to the Reporting Person under the Issuer's 2005 Equity Incentive Plan. The shares surrendered were valued based on the closing price of the Issuer's common stock on the vesting date.
  6. These shares were sold to cover estimated federal income taxes and capital gains taxes of the Reporting Person due upon the vesting of Restricted Stock Units in calendar 2010.